Application of whole-body FDG-PET for cancer screening in a cohort of hospital employees

Whole-body positron emission tomography/computed tomography with the glucose analog 2-[(18)F]fluoro-2-deoxy-d-glucose (FDG-PET/CT) has been extensively used to screen for underlying malignancies in asymptomatic individuals. We were able to survey a cohort of hospital employees using FDG-PET/CT and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chin, Liu, Chun-Peng, Cheng, Jin-Shiung, Chiu, Yu-Li, Chan, Hung-Pin, Peng, Nan-Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591093/
https://www.ncbi.nlm.nih.gov/pubmed/27858845
http://dx.doi.org/10.1097/MD.0000000000005131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591093/
https://www.ncbi.nlm.nih.gov/pubmed/27858845
http://dx.doi.org/10.1097/MD.0000000000005131

Ejemplares similares